Abstract

Molecular imaging is constantly growing in different areas of preclinical biomedical research. Several imaging methods have been developed and are continuously updated for both in vivo and in vitro applications, in order to increase the information about the structure, localization and function of molecules involved in physiology and disease. Along with these progresses, there is a continuous need for improving labeling strategies. In the last decades, the single domain antigen-binding fragments nanobodies (Nbs) emerged as important molecular imaging probes. Indeed, their small size (~15 kDa), high stability, affinity and modularity represent desirable features for imaging applications, providing higher tissue penetration, rapid targeting, increased spatial resolution and fast clearance. Accordingly, several Nb-based probes have been generated and applied to a variety of imaging modalities, ranging from in vivo and in vitro preclinical imaging to super-resolution microscopy. In this review, we will provide an overview of the state-of-the-art regarding the use of Nbs in several imaging modalities, underlining their extreme versatility and their enormous potential in targeting molecules and cells of interest in both preclinical and clinical studies.

Highlights

  • Molecular imaging has emerged as a key tool for the visualization of biological processes associated to a variety of diseases

  • Non-invasive in vivo imaging technologies, such as positron emission tomography (PET), single-photon emission tomography (SPECT), optical imaging (OI), magnetic resonance imaging (MRI) and ultrasound provide spatial and temporal information about the anatomical localization and metabolic status of biological processes in living animals: they lack the possibility to analyze events at cellular or sub-cellular resolution, a limitation that can be solved through the use of intravital or ex vivo microscopy technologies

  • Non-invasive in vivo imaging techniques, including PET, SPECT, OI and ultrasound, require the accumulation of specific probes targeting the tissue of interest, in order to achieve a high contrast signal compared to surrounding healthy tissue [13]

Read more

Summary

Introduction

Molecular imaging has emerged as a key tool for the visualization of biological processes associated to a variety of diseases. Non-invasive in vivo imaging technologies, such as positron emission tomography (PET), single-photon emission tomography (SPECT), optical imaging (OI), magnetic resonance imaging (MRI) and ultrasound provide spatial and temporal information about the anatomical localization and metabolic status of biological processes in living animals: they lack the possibility to analyze events at cellular or sub-cellular resolution, a limitation that can be solved through the use of intravital or ex vivo microscopy technologies. For this reason, the use of multiple imaging modalities has become preferred [6,7,8]. We will discuss their recent application in in vitro sub-cellular microscopy and super-resolution techniques

Nanobodies
Generation of Nanobody Libraries
Nanobodies as Imaging Tools
Imaging Tumor
Imaging Tumor Cells
Imaging Tumor Microenvironment
Imaging Tumor Immune Checkpoint
Theranostic Approach Using Nbs
Imaging Inflammatory Diseases
Nanobodies in Fluorescence-Guided Surgery
Nanobodies in Microscopy
Findings
Conclusive Remarks

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.